Skip to main content
Clinical Trials/NCT02011529
NCT02011529
Completed
Not Applicable

A Team Approach to Improve the Quality of Diabetes Care for Patients With Schizophrenia

University of Washington1 site in 1 country35 target enrollmentNovember 2013
ConditionsDiabetes

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Diabetes
Sponsor
University of Washington
Enrollment
35
Locations
1
Primary Endpoint
Hemoglobin A1c
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

This proposal aims to demonstrate the feasibility and acceptability of adapting TEAMcare for patients with schizophrenia. The aim of this innovative mental health center-based team intervention is to improve diabetes, cardiovascular and psychiatric outcomes among patients with poorly controlled type 2 diabetes. The study will be conducted in two phases over the 2-year grant period.

Phase 1. Development of the adapted TEAMcare intervention and training of team members.

Phase 2. During year 2, we will implement the intervention on the caseload of 40 outpatients at Harborview Mental Health Services with schizophrenia and poorly controlled type 2 diabetes. The intervention involves the management of subjects' diabetes, hypertension, and hyperlipidemia by a CMHC diabetes team for 6 months (advanced nurse specialist on-site at supervised in weekly meetings by a psychiatrist and a UW Diabetes Center endocrinologist).

The primary aim of this pilot research grant is to evaluate the feasibility of implementing this complex intervention, in order to guide the design of a larger scale efficacy study (R01). Both process and outcome measures will be evaluated at baseline, and at 3- and 6-month follow-up visits for the 40 subjects enrolled in this feasibility trial.

Registry
clinicaltrials.gov
Start Date
November 2013
End Date
September 2015
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Lydia Chwastiak

Associate Professor

University of Washington

Eligibility Criteria

Inclusion Criteria

  • adult (18-70 years);
  • enrolled to receive mental health treatment at Harborview Mental Health Services or Downtown Emergency Services Mental Health center
  • a diagnosis of type 2 diabetes mellitus or cardiovascular disease
  • Hemoglobin A1c \>8 or BP \> 140/90

Exclusion Criteria

  • cognitive, hearing, or language impairment that would preclude a subject from providing informed consent;
  • current suicidality, homicidality, or grave disability that requires psychiatric hospitalization;
  • current substance abuse or dependence, as defined by SCID.

Outcomes

Primary Outcomes

Hemoglobin A1c

Time Frame: 6 months

Secondary Outcomes

  • LDL cholesterol(6 months)
  • Blood Pressure(6 months)

Study Sites (1)

Loading locations...

Similar Trials